Visual summary
Monitor cultures, clinical response, drug-related adverse effects, and access planning. Treatment success requires resolution of the infection pathway.
Illustration updated October 18, 2026. Educational schematic. Imaging and microscopy panels are illustrations, not patient studies. Full teaching text and sources follow.
Diagram description
Access infection can reach a heart valve. Vascular access — Potential bloodstream entry; Bacteremia — Obtain clinically indicated cultures; Valve infection — Imaging and source evaluation; Systemic consequences — Embolic or immune injury may occur. Manage infection and source control together; a dressing problem can be a systemic infection. The infographic uses anatomical illustrations and integrated labels; the complete teaching text and evidence are below.
Text version
High exposure, high stakes
Repeated vascular access and bloodstream infection risk make endocarditis an important consideration in dialysis patients with persistent bacteremia or systemic illness.
Look for more than fever
Embolic signs, new cardiac findings, access abnormalities, persistent positive cultures, and unexplained deterioration can reveal a deeper infection.
Define the organism and source
Blood cultures, appropriate echocardiography, access assessment, and susceptibility testing guide diagnosis and treatment. Prior antibiotics can complicate interpretation.
Coordinate treatment
Coordinate infectious disease, nephrology, cardiology, and surgery. Choose susceptibility-directed treatment and dialysis-adjusted exposure; intermittent dialysis-day-only regimens are not established replacements for standard therapy.
Do not ignore source control
An infected catheter, persistent bacteremia, valve complications, or metastatic infection may prevent cure despite an apparently appropriate antibiotic.
Follow for relapse and harm
Monitor cultures, clinical response, drug-related adverse effects, and access planning. Treatment success requires resolution of the infection pathway.
Supporting evidence
- 2023 ESC Guidelines for the management of endocarditis.
- Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis.
- KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update.
- Use of pharmacokinetic and pharmacodynamic principles to determine optimal administration of daptomycin in patients receiving standardized thrice-weekly hemodialysis.
